These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30368751)

  • 1. From Cancer Immunoediting to New Strategies in Cancer Immunotherapy: The Roles of Immune Cells and Mechanics in Oncology.
    Aragon-Sanabria V; Kim GB; Dong C
    Adv Exp Med Biol; 2018; 1092():113-138. PubMed ID: 30368751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Immunoediting in the Era of Immuno-oncology.
    Gubin MM; Vesely MD
    Clin Cancer Res; 2022 Sep; 28(18):3917-3928. PubMed ID: 35594163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for cancer immunotherapy: counter-immunoediting therapy.
    Liu S; Sun Q; Ren X
    J Hematol Oncol; 2023 Apr; 16(1):38. PubMed ID: 37055849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunoediting and resistance to T cell-based immunotherapy.
    O'Donnell JS; Teng MWL; Smyth MJ
    Nat Rev Clin Oncol; 2019 Mar; 16(3):151-167. PubMed ID: 30523282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
    Ariyasu R; Nishikawa H
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy.
    Pérez-Romero K; Rodríguez RM; Amedei A; Barceló-Coblijn G; Lopez DH
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
    Schreiber RD; Old LJ; Smyth MJ
    Science; 2011 Mar; 331(6024):1565-70. PubMed ID: 21436444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of the cancer immunoediting hypothesis.
    Desai R; Coxon AT; Dunn GP
    Semin Cancer Biol; 2022 Jan; 78():63-77. PubMed ID: 33711414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances of RNA m
    Ma S; Barr T; Yu J
    Cancer Treat Res; 2023; 190():49-94. PubMed ID: 38112999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From mice to humans: developments in cancer immunoediting.
    Teng MW; Galon J; Fridman WH; Smyth MJ
    J Clin Invest; 2015 Sep; 125(9):3338-46. PubMed ID: 26241053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review.
    Kareva I
    Stem Cells; 2019 Oct; 37(10):1273-1280. PubMed ID: 31260163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing.
    Bernier J
    Crit Rev Oncol Hematol; 2016 Dec; 108():97-108. PubMed ID: 27931845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.
    Ward JP; Gubin MM; Schreiber RD
    Adv Immunol; 2016; 130():25-74. PubMed ID: 26922999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.
    Mittal D; Gubin MM; Schreiber RD; Smyth MJ
    Curr Opin Immunol; 2014 Apr; 27():16-25. PubMed ID: 24531241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo imaging of tumor-infiltrating immune cells: implications for cancer immunotherapy.
    Zeelen C; Paus C; Draper D; Heskamp S; Signore A; Galli F; Griessinger CM; Aarntzen EH
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):56-77. PubMed ID: 29191000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research.
    Overgaard NH; Fan TM; Schachtschneider KM; Principe DR; Schook LB; Jungersen G
    ILAR J; 2018 Dec; 59(3):247-262. PubMed ID: 30476148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.
    Mizuno S; Yamaguchi R; Hasegawa T; Hayashi S; Fujita M; Zhang F; Koh Y; Lee SY; Yoon SS; Shimizu E; Komura M; Fujimoto A; Nagai M; Kato M; Liang H; Miyano S; Zhang Z; Nakagawa H; Imoto S
    Sci Rep; 2021 Aug; 11(1):15713. PubMed ID: 34344966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse immunoediting: When immunity is edited by antigen.
    Merlo A; Dalla Santa S; Dolcetti R; Zanovello P; Rosato A
    Immunol Lett; 2016 Jul; 175():16-20. PubMed ID: 27131431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel avenues in immunotherapies for colorectal cancer.
    Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.
    von Locquenghien M; Rozalén C; Celià-Terrassa T
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.